Analogues ultra-rapides de l’insuline et délivrance automatisée de l’insuline, un réel pas en avant ?
-
Published:2024-06
Issue:4
Volume:18
Page:301-309
-
ISSN:1957-2557
-
Container-title:Médecine des Maladies Métaboliques
-
language:fr
-
Short-container-title:Médecine des Maladies Métaboliques
Reference29 articles.
1. Better TIR, HbA1c, and less hypoglycemia in closed-loop insulin system in patients with type 1 diabetes: a meta-analysis;Jiao;BMJ Open Diabetes Res Care,2022
2. Consensus recommendations for the use of automated insulin delivery technologies in clinical practice;Phillip;Endocr Rev,2023
3. Faster-acting insulin aspart: earlier onset of appearance and greater early pharmacokinetic and pharmacodynamic effects than insulin aspart;Heise;Diabetes Obes Metab,2015
4. Fast-acting insulin aspart improves glycemic control in basal-bolus treatment for type 1 diabetes: results of a 26-week multicenter, active-controlled, treat-to-target, randomized, parallel-group trial (onset 1);Russell-Jones;Diabetes Care,2017
5. Ultrarapid Lispro improves postprandial glucose control compared with lispro in patients with type 1 diabetes: Results from the 26-week PRONTO-T1D study;Klaff;Diabetes Obes Metab,2020